Clinical Trial Update: Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis [NA]

View source ↗

Summary

This clinical trial update reports an observed increase in the lower-rate pacing setting in patients with transthyretin amyloid cardiomyopathy (ATTR-CM); the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis
• Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: Region Skane | Conditions: Cardiac Amyloidosis, Pacemaker | NA | Status: NOT_YET_RECRUITING